Inactive Instrument

Insiders Beigene Ltd Hong Kong S.E.

Equities

End-of-day quote Hong Kong S.E. Other stock markets
- ^HKD	-

Apr. 23	Sector Update: Health Care Stocks Rise in Afternoon Trading	MT
Apr. 23	BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise	MT

BeiGene, Ltd. Announces Executive Changes	Mar. 20	CI
Beigene Insider Sold Shares Worth $8,368,017, According to a Recent SEC Filing	Mar. 14	MT
Beigene, Ltd. Announces Board Changes	Jan. 23	CI
BeiGene, Ltd. Announces Board Changes	Jan. 23	CI
Beigene, Ltd. Announces Change of Chair of Audit Committee	23-09-14	CI
Insider Sell: Beigene	23-08-02	MT
Insider Sell: Beigene	23-06-27	MT
Insider Sell: Beigene	23-06-27	MT
Insider Sell: Beigene	23-06-27	MT
Insider Sell: Beigene	23-06-09	MT
Insider Sell: Beigene	23-05-10	MT
BeiGene, Ltd. Announces Directors Names Who Are Not Standing for Re-Election	23-04-27	CI
BeiGene, Ltd. Announces Re-Designation of Anthony C. Hooper as an Independent Non- Executive Director	23-04-17	CI
BeiGene Announces the Appointment of Julius Pryor III as Global Head of Diversity and Health Equity	23-03-30	CI
Insider Sell: BeiGene	23-03-13	MT
Insider Sell: Beigene	23-01-17	MT
Insider Sell: Beigene	23-01-12	MT
Insider Sell: Beigene	23-01-11	MT
Beigene, Ltd. Announces Change of Co-Chair of Scientific Advisory Committee	22-11-21	CI
Insider Sell: Beigene	22-11-17	MT

No results for this search